期刊文献+

Cirrhotic cardiomyopathy:Isn't stress evaluation alwaysrequired for the diagnosis? 被引量:5

下载PDF
导出
摘要 AIM:To describe the proportion of patients with cirrhotic cardiomyopathy(CCM) evaluated by stress echocardiography and investigating its association with the severity of liver disease.METHODS:A cross-sectional study was conducted.Cirrhotic patients without risk factors for cardiovascular disease were included.Data regarding etiology and severity of liver disease(Child-Pugh score and model for end-stage liver disease),presence of ascites and gastroesophageal varices,pro-brain natriuretic peptide(proBNP) and corrected QT(QTc) interval were collected.Dobutamine stress echocardiography(conventional and tissue Doppler imaging) was performed.CCM was considered present when diastolic and/or systolic dysfunction was diagnosed at rest or after pharmacological stress.Therapy interfering with cardiovascular system was suspended 24 h before the examination.RESULTS:Twenty-six patients were analyzed,17(65.4%) Child-Pugh A,mean model for end-stage liver disease(MELD) score of 8.7.The global proportion of patients with CCM was 61.5%.At rest,only 2(7.7%)patients had diastolic dysfunction and none of the patients had systolic dysfunction.Dobutamine stress echocardiography revealed the presence of diastolic dysfunction in more 6(23.1%) patients and of systolic dysfunction in 10(38.5%) patients.QTc interval prolongation was observed in 68.8%of the patients and increased pro-BNP levels in 31.2%of them.There was no association between the presence of CCM and liver impairment assessed by Child-Pugh score or MELD(P= 0.775,P= 0.532,respectively).Patients with QTc interval prolongation had a significant higher rate of gastroesophageal varices comparing with those without QTc interval prolongation(95.0%vs 50.0%,P= 0.028).CONCLUSION:CCM is a frequent complication of cirrhosis that is independent of liver impairment.Stress evaluation should always be performed,otherwise it will remain an underdiagnosed condition. AIM:To describe the proportion of patients with cirrhotic cardiomyopathy(CCM) evaluated by stress echocardiography and investigating its association with the severity of liver disease.METHODS:A cross-sectional study was conducted.Cirrhotic patients without risk factors for cardiovascular disease were included.Data regarding etiology and severity of liver disease(Child-Pugh score and model for end-stage liver disease),presence of ascites and gastroesophageal varices,pro-brain natriuretic peptide(proBNP) and corrected QT(QTc) interval were collected.Dobutamine stress echocardiography(conventional and tissue Doppler imaging) was performed.CCM was considered present when diastolic and/or systolic dysfunction was diagnosed at rest or after pharmacological stress.Therapy interfering with cardiovascular system was suspended 24 h before the examination.RESULTS:Twenty-six patients were analyzed,17(65.4%) Child-Pugh A,mean model for end-stage liver disease(MELD) score of 8.7.The global proportion of patients with CCM was 61.5%.At rest,only 2(7.7%)patients had diastolic dysfunction and none of the patients had systolic dysfunction.Dobutamine stress echocardiography revealed the presence of diastolic dysfunction in more 6(23.1%) patients and of systolic dysfunction in 10(38.5%) patients.QTc interval prolongation was observed in 68.8%of the patients and increased pro-BNP levels in 31.2%of them.There was no association between the presence of CCM and liver impairment assessed by Child-Pugh score or MELD(P= 0.775,P= 0.532,respectively).Patients with QTc interval prolongation had a significant higher rate of gastroesophageal varices comparing with those without QTc interval prolongation(95.0%vs 50.0%,P= 0.028).CONCLUSION:CCM is a frequent complication of cirrhosis that is independent of liver impairment.Stress evaluation should always be performed,otherwise it will remain an underdiagnosed condition.
出处 《World Journal of Hepatology》 CAS 2016年第3期200-206,共7页 世界肝病学杂志(英文版)(电子版)
  • 相关文献

参考文献37

  • 1Kowalski HJ, Abelmann WH. The cardiac output at rest inLaennec’s cirrhosis. J Clin Invest 1953; 32: 1025-1033 [PMID:13096569].
  • 2Al Hamoudi W, Lee SS. Cirrhotic cardiomyopathy. Ann Hepatol2006; 5: 132-139 [PMID: 17060868].
  • 3Lee RF, Glenn TK, Lee SS. Cardiac dysfunction in cirrhosis.Best Pract Res Clin Gastroenterol 2007; 21: 125-140 [PMID:17223501].
  • 4Baik SK, Fouad TR, Lee SS. Cirrhotic cardiomyopathy. OrphanetJ Rare Dis 2007; 2: 15 [PMID: 17389039].
  • 5Mler S, Henriksen JH. Cirrhotic cardiomyopathy. J Hepatol 2010;53: 179-190 [PMID: 20462649 DOI: 10.1016/j.jhep.2010.02.023].
  • 6Mler S, Bernardi M. Interactions of the heart and the liver. EurHeart J 2013; 34: 2804-2811 [PMID: 23853073 DOI: 10.1093/eurheartj/eht246].
  • 7Mler S, Hove JD, Dixen U, Bendtsen F. New insights intocirrhotic cardiomyopathy. Int J Cardiol 2013; 167: 1101-1108[PMID: 23041091 DOI: 10.1016/j.ijcard.2012.09.089].
  • 8Zardi EM, Abbate A, Zardi DM, Dobrina A, Margiotta D, VanTassell BW, Afeltra A, Sanyal AJ. Cirrhotic cardiomyopathy. J AmColl Cardiol 2010; 56: 539-549 [PMID: 20688208 DOI: 10.1016/j.jacc.2009].
  • 9Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart ofthe matter. Hepatology 1996; 24: 451-459 [PMID: 8690419].
  • 10Pozzi M, Carugo S, Boari G, Pecci V, de Ceglia S, Maggiolini S,Bolla GB, Roffi L, Failla M, Grassi G, Giannattasio C, ManciaG. Evidence of functional and structural cardiac abnormalities incirrhotic patients with and without ascites. Hepatology 1997; 26:1131-1137 [PMID: 9362352].

同被引文献24

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部